India to supply Pneumonia Vaccine to low-income nations
The Pune based Serum Institute of India is to supply Pneumonia vaccine to low-income countries. The Institute is one of the leading manufacturers of vaccines and immunobiological drugs.
Highlights
The Serum Institute of India and UNICEF have signed an agreement to supply pneumonia vaccine to low income countries. Under the agreement, the institutes are to provide 10 million Pneumococcal Conjugate Vaccine that will help prevent pneumonia to low income countries every year
The Pune based Serum Institute of India is to supply Pneumonia vaccine to low-income countries. The Institute is one of the leading manufacturers of vaccines and immunobiological drugs.
Highlights
The Serum Institute of India and UNICEF have signed an agreement to supply pneumonia vaccine to low income countries. Under the agreement, the institutes are to provide 10 million Pneumococcal Conjugate Vaccine that will help prevent pneumonia to low income countries every year.
GAVI Alliance
The Serum Institute of India along with UNICEF and GAVI alliance are to supply the vaccine at 2 USD per does. This is 43% less than GAVI price of 3.50 USD under the Advance Market Commitment
Advance Market Commitment
Under Advance Market Commitment, the GAVI alliance provided incentives to the pharmaceutical companies to develop and produce suitable vaccines. This was done to provide sustainable prices to the vaccines.
The AMC was launched in 2009. It has so far prevented deaths of 700,000 children in 60 developing countries. The AMC programme is set to end this year (2020). The programme was launched by Canada, UK, Russia, Bill and Melinda Gates Foundation and Norway.
Background
Pneumonia is the biggest killer of children in the world that takes the life of a child every 39 seconds.
GAVI Alliance
The Serum Institute of India along with UNICEF and GAVI alliance are to supply the vaccine at 2 USD per does. This is 43% less than GAVI price of 3.50 USD under the Advance Market Commitment
Advance Market Commitment
Under Advance Market Commitment, the GAVI alliance provided incentives to the pharmaceutical companies to develop and produce suitable vaccines. This was done to provide sustainable prices to the vaccines.
The AMC was launched in 2009. It has so far prevented deaths of 700,000 children in 60 developing countries. The AMC programme is set to end this year (2020). The programme was launched by Canada, UK, Russia, Bill and Melinda Gates Foundation and Norway.
Background
Pneumonia is the biggest killer of children in the world that takes the life of a child every 39 seconds.
Related Posts
Month: Current Affairs - June, 2020